Novel pyrrole carboxamide inhibitors of JAK2 as potential treatment of myeloproliferative disordersMaria Gabriella Brasca, Daniele Donati, Nicoletta Colombo et al.|Bioorganic & Medicinal Chemistry|2015Cited by 20
Abstract 2082: NMS-E668, a potent and selective RET kinase inhibitor characterized by specificity towards VEGFR2 and high antitumor efficacy against RET-driven modelsElena Ardini, Maria Menichincheri, Patrizia Banfi et al.|Cancer Research|2017Cited by 1
517 Identification and characterization of selective MELK kinase inhibitorsPatrizia Carpinelli, Arturo Galvani, Nadia Amboldi et al.|European Journal of Cancer|2014Cited by 0
Abstract A179: NMS-P113, a novel orally available JAK2 selective inhibitorPaola Gnocchi, Arturo Galvani, Maria Gabriella Brasca et al.|Molecular Cancer Therapeutics|2015Cited by 0
Abstract 3795: Novel and selective MELK kinase inhibitors active in breast cancer cell linesPatrizia Carpinelli, Alessia Montagnoli, Marisa Montemartini et al.|Cancer Research|2016Cited by 0